Molecular profiling has transformed cancer care, but 30% of high-risk pediatric cancers do not have actionable therapeutic targets, limiting personalized treatment options and negatively affecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback